- Home
- GRND vs BHC Comparison
GRND vs BHC Comparison
Compare GRND & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRND
- BHC
- Stock Information
- Founded
- GRND 2009
- BHC N/A
- Country
- GRND United States
- BHC Canada
- Employees
- GRND N/A
- BHC N/A
- Industry
- GRND Computer Software: Prepackaged Software
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- GRND Technology
- BHC Health Care
- Exchange
- GRND Nasdaq
- BHC Nasdaq
- Market Cap
- GRND 3.2B
- BHC 2.9B
- IPO Year
- GRND N/A
- BHC N/A
- Fundamental
- Price
- GRND $18.00
- BHC $7.31
- Analyst Decision
- GRND Strong Buy
- BHC Hold
- Analyst Count
- GRND 5
- BHC 5
- Target Price
- GRND $20.00
- BHC $7.20
- AVG Volume (30 Days)
- GRND 1.3M
- BHC 3.2M
- Earning Date
- GRND 03-05-2025
- BHC 02-19-2025
- Dividend Yield
- GRND N/A
- BHC N/A
- EPS Growth
- GRND N/A
- BHC N/A
- EPS
- GRND N/A
- BHC N/A
- Revenue
- GRND $319,101,000.00
- BHC $9,625,000,000.00
- Revenue This Year
- GRND $33.22
- BHC $10.68
- Revenue Next Year
- GRND $23.83
- BHC $3.66
- P/E Ratio
- GRND N/A
- BHC N/A
- Revenue Growth
- GRND 31.79
- BHC 9.91
- 52 Week Low
- GRND $7.93
- BHC $3.96
- 52 Week High
- GRND $18.70
- BHC $11.46
- Technical
- Relative Strength Index (RSI)
- GRND 52.95
- BHC 56.03
- Support Level
- GRND $17.86
- BHC $6.12
- Resistance Level
- GRND $18.64
- BHC $7.49
- Average True Range (ATR)
- GRND 0.40
- BHC 0.31
- MACD
- GRND -0.06
- BHC 0.07
- Stochastic Oscillator
- GRND 33.96
- BHC 86.86
About GRND Grindr Inc.
Grindr Inc is a social networking app for gay, bi, trans, and queer people. It is a social network that brings together gay and bisexual men who want to meet other men close to them in a completely discreet and anonymous way, without having to give any personal information or having to fill out a profile with confidential information in order to register.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.